Hi-C sequencing to identify clinically actionable fusions in non–small cell lung cancer missed by other sequencing technologies
Levine, et al.
ASCO 2026 - Chicago, IL
Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
Bradshaw, et al.
AACR 2026 - San Diego, CA
Targetable fusions and rearrangement detection in gastrointestinal and lungtumors leveraging low-pass whole-genome sequencing based Hi-C chemistry
Sigal, et al.
AACR 2026 - San Diego, CA
Actionable fusions and rearrangements can be efficiently identified by Hi-C whole genome sequencing in lung tumors
Hastie, et al.
AACR 2026 - San Diego, CA
Molecular Analysis of Driver Negative Lung Cancer for Rearrangements and Fusions Using a New HiC Sequencing Assay
Ricketts, et al.
2025 World Conference on Lung Cancer - Barcelona, Spain
Aventa FusionPlus based on Hi-C FFPE Sequencing Detects Fusions Genome-Wide with High Sensitivity in Solid Tumors
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX
Detection of Gene Fusions and Rearrangements in Formalin-Fixed, Paraffin-Embedded Solid Tumor Specimens Using High-Throughput Chromosome Conformation Capture
Galbraith, et al.
J Mol Diagn. 27(5):346.
Evaluation of Hi-C Sequencing for Detection of Gene Fusions in Hematologic and Solid Tumor Pediatric Cancer Samples
Schmitt, et al.
Cancers (Basel). 16(17):2936.